Application 220367
- Type
- ANDA
- Sponsor
- STERANCO HLTHCARE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NYSTATIN | NYSTATIN | SUSPENSION;ORAL | 100,000 UNITS/ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A220367-001 | NYSTATIN | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | 2026-02-05 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A220367-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | 2026-02-05 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A220367-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | 2026-02-05 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A220367-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2026-02-05 | 011fe1cb6892… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220367-001 | NYSTATIN | 100,000 UNITS/ML | SUSPENSION / ORAL | AA | 2026-02-05 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A220367-001 | AA | 1 | 011fe1cb6892… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220367-001 | AA | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nystatin | NYSTATIN | RedPharm Drug, Inc | f4c298d5-b012-7b56-e053-2a95a90a3d55 | 2026-01-24 | Adverse reactions | Nystatin NYSTATIN |
| NYSTATIN | NYSTATIN | ATLANTIC BIOLOGICALS CORP. | 5c08148f-83e5-4f14-b0d3-af8d2c26062e | 2026-01-13 | Adverse reactions | NYSTATIN NYSTATIN |
| Nystatin | NYSTATIN | Chartwell RX, LLC | 30175930-f5fa-403d-a3ac-3bdbbe723641 | 2025-12-17 | Adverse reactions | Nystatin NYSTATIN |
| NYSTATIN | NYSTATIN | Kesin Pharma Corporation | 43817169-bbe8-58ee-e063-6294a90a1250 | 2025-12-11 | Adverse reactions | NYSTATIN NYSTATIN |
| Nystatin | NYSTATIN | Chartwell Governmental & Specialty RX, LLC | 88a0a22e-8d6b-42aa-b225-2d57fb5b3a97 | 2025-11-12 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN CREAM | NuCare Pharmaceuticals, Inc. | 42f21220-c68a-d748-e063-6394a90a1e2f | 2025-11-06 | Adverse reactions | Nystatin |
| Nystatin | NYSTATIN | Bryant Ranch Prepack | b71356cf-7b6e-4ca0-9571-c80fd0d846cb | 2025-10-23 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN | Cardinal Health 107, LLC | 56aca0e2-8691-4701-beba-e2315524709f | 2025-10-23 | Adverse reactions | Nystatin NYSTATIN |
| Nystop | NYSTATIN | Bryant Ranch Prepack | 64041bdf-1207-47f6-93f3-bc4656a7d2ae | 2025-10-21 | Adverse reactions | NYSTATIN |
| Nystop | NYSTATIN | Bryant Ranch Prepack | affea013-4f09-4e7d-a696-9f501d379af6 | 2025-10-21 | Adverse reactions | NYSTATIN |
| Nystatin | NYSTATIN | Bryant Ranch Prepack | b6aa24e6-1acb-4fd3-9ec7-11b1a69c1598 | 2025-10-08 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN | Northstar Rx LLC | 9e6d0b0d-a68f-46aa-a707-3110ecb931b4 | 2025-09-30 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN | Bryant Ranch Prepack | 840eebe8-5de2-40c5-acfd-03a98b2e790e | 2025-09-23 | Adverse reactions | Nystatin NYSTATIN |
| Nystatin | NYSTATIN | AvKARE | 8fd35f97-5405-2160-ca0f-35034ecd5a92 | 2025-09-18 | Adverse reactions | Nystatin NYSTATIN |
| NYSTATIN | NYSTATIN | Kanchan Healthcare Inc | 90a52c3f-3ef7-4f3b-9fe5-40af408e9f2a | 2025-09-12 | Adverse reactions | NYSTATIN NYSTATIN |
| Nystop | NYSTATIN | Bryant Ranch Prepack | 69ebb4dd-f45d-448d-97cd-3f8935493975 | 2025-08-26 | Adverse reactions | NYSTATIN |
| nystatin | NYSTATIN | Bryant Ranch Prepack | a5711dbe-f71c-435c-91f2-38c357532d18 | 2025-08-19 | Adverse reactions | nystatin NYSTATIN |
| Nyamyc | NYSTATIN | Upsher-Smith Laboratories, LLC | 01b44f91-9b68-464a-9693-b5d3e793bf3c | 2025-07-09 | Adverse reactions | NYSTATIN |
| Nystatin | NYSTATIN | Sun Pharmaceutical Industries, Inc. | 4d845b3f-ca26-4c47-b424-b6d783cc10e5 | 2025-07-03 | Adverse reactions | Nystatin NYSTATIN |
| nystatin | NYSTATIN | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | e87b8480-987d-4f82-87bf-cf831d6984a1 | 2025-06-23 | Adverse reactions | nystatin NYSTATIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.